Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5.
about
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switchSelective up-regulation of PDE1B2 upon monocyte-to-macrophage differentiationCharacteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesisMyb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressorGM-CSF: An immune modulatory cytokine that can suppress autoimmunityCompound SFTPB 1549C-->GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiencyAlveolar surfactant homeostasis and the pathogenesis of pulmonary diseaseThe receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissuesBatf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization.Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection.Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesisSpecificity of signaling by hematopoietic cytokine receptors: instructive versus permissive effects.Pulmonary alveolar proteinosis in children on La Réunion Island: a new inherited disorder?The molecular basis of pulmonary alveolar proteinosisIL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis.Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.Pulmonary alveolar proteinosis: progress in the first 44 years.Role of GM-CSF signaling in cell-based tumor immunization.New approaches in the treatment of asthma.Clinical biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism.Interleukin-3 receptor in acute leukemia.The effect of erythropoietin on normal and neoplastic cells.The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.Crowding-dependent production of colony-stimulating factors by cultured syngeneic or allogeneic hematopoietic cellsPulmonary alveolar proteinosis: a review.Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.Pulmonary macrophage transplantation therapyTissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes.Cytokine and cytokine receptor pleiotropy and redundancy.Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.Genetic Basis of Children's Interstitial Lung Disease.JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.Regulation of haematopoiesis by growth factors - emerging insights and therapies.PPARs in alveolar macrophage biology.The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesisIL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.
P2860
Q24302076-0318A419-7956-4449-8E53-2ABC0AD3A7F2Q24557526-D1121D5F-D2CC-49DA-945E-A03FA35F1728Q24657836-FAD1D11B-E492-45EC-945E-D2ECD8F8C0ABQ24679404-9CB4E50D-B6A7-4903-82E0-6CACECEACB64Q27300691-CD306356-4D0A-4469-AFF5-5792A26BD94AQ28080640-1F4D80C3-A70C-4C79-AF19-039A136EFF81Q28138504-54A55279-1329-469A-AD0F-A8AC1C973412Q28261260-7EFEBD2A-BBFD-443C-B788-2B22964F853FQ28510383-1316631A-1B6E-4C70-8542-2C97DDA6BC77Q31040402-4C6CB3BF-82F8-4E6A-B416-C0817654010CQ31126222-75B148E5-83A5-498C-9993-6332DC8396E2Q31157006-D6DBF673-7702-4F5E-971F-15A38EF0BAC4Q33194891-6473789D-E772-45A1-9128-534EFED51E6CQ33540009-313B0F58-0D21-4DD3-BF7C-2DDA40F96E18Q33774873-A7305F6B-A949-4284-AC68-0672DCCE4021Q33835843-D106D4BE-3C3E-4906-AF6C-E9777CC47651Q33941375-831E7FEC-A801-4C18-AC6C-ABE304495E8AQ33959954-5C51CFA2-CBF9-4F73-96CA-8D0534CA13F3Q33988125-0CD73070-2090-4148-B2B6-EABB5285A869Q34139014-FD2EBFAF-4233-45AC-AAC3-92DCE61080D7Q34147010-40D06894-088B-403C-97CC-B0AA3E924538Q34192933-4206E1D8-1F19-4D98-93FF-7C8BD1626DF9Q34244200-BE60830A-9A60-45E8-989A-90C4A31FF74BQ34283145-771F5CA7-24EB-4344-A4B1-6EEDF46F6A1CQ34291437-93D160BB-7E6F-4446-875D-D8E111D8FCF3Q34304678-18546C66-7C44-4815-BD92-96CCDCA09A39Q34311645-2258BA74-664A-4919-B329-BAE16188CAB3Q34330124-ACDEB6A1-C953-4E2B-B2B3-C89697103D08Q34365898-81224EDE-1796-4226-BDFD-61DD96C54B33Q34402453-97803806-D36C-4040-A32A-03A0C10E620CQ34539736-E43DB0C4-B787-4859-B3F3-C5E8AFCAD802Q34650719-6B055882-8D3B-4E57-BA30-FCF42C676D79Q34693494-4A88E5BB-E598-4EDC-B53D-1AEFFA34D78AQ35197274-6C5E38A7-7C2C-47EC-980B-76FD73751566Q35513452-3ADED5ED-DD41-4141-82D3-7BC97FFA2172Q35635353-BE9F2921-F443-48D5-98D5-F1C126123AFBQ35790849-D0EBB64C-F523-45CF-90D2-DD49EB5D0AD9Q36121727-0740EA93-BF6B-4640-9F5B-57F546DEDAB7Q36141626-26939C35-E3FB-498C-84A9-4A7E99613F08Q36161397-78446B18-F350-4AC2-9D07-4AEC0775DCCD
P2860
Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5.
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Hematopoietic and lung abnorma ...... ctor and interleukins 3 and 5.
@ast
Hematopoietic and lung abnorma ...... ctor and interleukins 3 and 5.
@en
type
label
Hematopoietic and lung abnorma ...... ctor and interleukins 3 and 5.
@ast
Hematopoietic and lung abnorma ...... ctor and interleukins 3 and 5.
@en
prefLabel
Hematopoietic and lung abnorma ...... ctor and interleukins 3 and 5.
@ast
Hematopoietic and lung abnorma ...... ctor and interleukins 3 and 5.
@en
P2093
P2860
P356
P1476
Hematopoietic and lung abnorma ...... ctor and interleukins 3 and 5.
@en
P2093
C C Drinkwater
C G Begley
N A Nicola
P2860
P304
P356
10.1073/PNAS.92.21.9565
P407
P577
1995-10-01T00:00:00Z